JP2023521837A5 - - Google Patents

Info

Publication number
JP2023521837A5
JP2023521837A5 JP2022562334A JP2022562334A JP2023521837A5 JP 2023521837 A5 JP2023521837 A5 JP 2023521837A5 JP 2022562334 A JP2022562334 A JP 2022562334A JP 2022562334 A JP2022562334 A JP 2022562334A JP 2023521837 A5 JP2023521837 A5 JP 2023521837A5
Authority
JP
Japan
Prior art keywords
composition according
protein
mutant
composition
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022562334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521837A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/027355 external-priority patent/WO2021211760A1/en
Publication of JP2023521837A publication Critical patent/JP2023521837A/ja
Publication of JP2023521837A5 publication Critical patent/JP2023521837A5/ja
Pending legal-status Critical Current

Links

JP2022562334A 2020-04-14 2021-04-14 大きな配列の汎コロナウイルスワクチン組成物 Pending JP2023521837A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063009907P 2020-04-14 2020-04-14
US63/009,907 2020-04-14
US202063084421P 2020-09-28 2020-09-28
US63/084,421 2020-09-28
PCT/US2021/027355 WO2021211760A1 (en) 2020-04-14 2021-04-14 Large sequence pan-coronavirus vaccine compositions

Publications (2)

Publication Number Publication Date
JP2023521837A JP2023521837A (ja) 2023-05-25
JP2023521837A5 true JP2023521837A5 (https=) 2024-04-22

Family

ID=78084328

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022562334A Pending JP2023521837A (ja) 2020-04-14 2021-04-14 大きな配列の汎コロナウイルスワクチン組成物

Country Status (9)

Country Link
US (1) US20230226173A1 (https=)
EP (3) EP4135764A4 (https=)
JP (1) JP2023521837A (https=)
KR (1) KR20230002571A (https=)
CN (1) CN116033920A (https=)
AU (1) AU2021254768A1 (https=)
CA (1) CA3178834A1 (https=)
IL (1) IL297335A (https=)
WO (3) WO2021211749A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12558415B2 (en) 2020-04-14 2026-02-24 The Regents Of The University Of California Broad-spectrum multi-antigen pan-coronavirus vaccine
IL297419B2 (en) 2020-04-22 2025-02-01 BioNTech SE Coronavirus vaccine
WO2022013609A1 (en) * 2020-07-13 2022-01-20 Immunovaccine Technologies, Inc. Sars-cov-2 vaccine compositions and methods of preparation and use
EP4333868A1 (en) * 2021-05-04 2024-03-13 King Abdullah University Of Science And Technology Immuogenic compositions of mutant sars-cov-2 n protein and gene and methods of use thereof
MX2023013081A (es) * 2021-05-05 2024-01-15 Novavax Inc Composiciones de coronavirus e influenza y métodos para utilizarlas.
CN113185586B (zh) * 2021-05-18 2023-01-17 深圳市因诺转化医学研究院 SARS-CoV-2编码蛋白来源的T细胞表位多肽及其应用
AU2022308712A1 (en) * 2021-07-09 2023-12-21 Atossa Therapeutics, Inc. Compositions and methods to increase coronavirus immune response
WO2023283642A2 (en) * 2021-07-09 2023-01-12 Modernatx, Inc. Pan-human coronavirus concatemeric vaccines
WO2023044542A1 (en) * 2021-09-24 2023-03-30 The University Of Adelaide Sars cov-2 vaccine
CN114395017B (zh) * 2021-10-29 2024-08-13 中国科学院深圳先进技术研究院 SARS-CoV-2病毒样颗粒的制备方法及其应用
EP4176898A1 (en) * 2021-11-08 2023-05-10 Charité - Universitätsmedizin Berlin Pan sars-cov2 vaccine antigen
US12186387B2 (en) 2021-11-29 2025-01-07 BioNTech SE Coronavirus vaccine
CN114181320B (zh) * 2021-12-09 2023-04-25 新疆医科大学第一附属医院 一种针对新冠原始株和变异株的重组多表位疫苗rSMEV及其应用
CN114478716B (zh) * 2021-12-28 2024-05-28 梅州市人民医院(梅州市医学科学院) 一种多肽组合及其在新型冠状病毒抗体检测中的应用
WO2023159082A2 (en) * 2022-02-15 2023-08-24 Ohio State Innovation Foundation Nanotechnology based intranasal vaccine for covid-19 comprising chitosan
WO2023240159A2 (en) * 2022-06-07 2023-12-14 The Regents Of The University Of California Sars-cov-2 multi-antigen universal vaccines
WO2024002985A1 (en) 2022-06-26 2024-01-04 BioNTech SE Coronavirus vaccine
WO2024011163A1 (en) * 2022-07-06 2024-01-11 Georgia State University Research Foundation, Inc. Coronavirus vaccines and methods of use thereof
WO2024064965A2 (en) * 2022-09-23 2024-03-28 Advanced Rna Vaccine (Arv) Technologies, Inc. Nucleic acid-based universal vaccine and methods of use thereof
WO2024074634A1 (en) * 2022-10-06 2024-04-11 BioNTech SE Rna compositions targeting claudin-18.2
CN116041540B (zh) * 2022-11-18 2025-10-17 中山大学 一种增强新冠突变株疫苗广谱性的方法及新冠广谱疫苗
WO2024191944A2 (en) * 2023-03-10 2024-09-19 The Regents Of The University Of California Broad-spectrum multi-antigen pan-coronavirus vaccine
WO2024206843A2 (en) * 2023-03-31 2024-10-03 University Of Kansas Compositions including modified coronavirus vaccines and uses thereof
WO2024222737A1 (zh) * 2023-04-28 2024-10-31 北京先声祥瑞生物制品股份有限公司 工程化的mRNA及其用途
CN117903264B (zh) * 2023-10-26 2026-04-03 中国人民解放军海军军医大学 新冠病毒SARS-CoV-2 HLA-A2限制性表位肽及应用
CN117330750A (zh) * 2023-12-01 2024-01-02 北京生物制品研究所有限责任公司 一种筛选新冠病毒早期毒种的方法和制造疫苗的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US38A (en) 1836-10-04 Horizontal boot-clamp
US4079A (en) 1845-06-10 Corn-shei
FR1601438A (https=) 1968-10-17 1970-08-24
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4131648A (en) 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4304767A (en) 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4946931A (en) 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US5968543A (en) 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
AU6526100A (en) 1999-08-06 2001-03-05 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
WO2005012337A2 (en) * 2003-07-15 2005-02-10 Crucell Holland B.V. Antigenic peptides of sars coronavirus and uses thereof
SG128680A1 (en) * 2003-07-22 2007-01-30 Crucell Holland Bv Binding molecules against sars-coronavirus and uses thereof
KR101255016B1 (ko) * 2004-04-09 2013-04-17 와이어쓰 엘엘씨 소포성 구내염 바이러스의 상승적 감쇠, 그의 벡터 및 그의 면역원성 조성물
ES2361000T3 (es) * 2004-04-28 2011-06-13 The Trustees Of The University Of Pennsylvania Suministro secuencial de moléculas inmunogénicas mediante administraciones de un adenovirus y de un virus adeno-asociado.
EP1882187A4 (en) * 2005-05-12 2010-10-20 Merck Sharp & Dohme SYSTEM AND METHOD FOR THE AUTOMATED SELECTION OF T-CELL EPITOPES
AU2007281934B2 (en) * 2006-01-18 2012-11-15 University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
ES2389121T3 (es) * 2007-02-27 2012-10-23 Wyeth Llc Composiciones inmunogénicas para el tratamiento y prevención de infecciones en animales
WO2009117134A2 (en) * 2008-03-21 2009-09-24 National Institutes Of Health Aerosolized genetic vaccines and methods of use
WO2010037402A1 (en) * 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
NZ602504A (en) * 2008-11-18 2014-01-31 Beth Israel Hospital Antiviral vaccines with improved cellular immunogenicity
MX2011010977A (es) * 2009-04-17 2012-02-29 Us Health Composiciones inmunoterapeuticas combinadas contra cancer y metodos.
CN101792491B (zh) * 2009-11-05 2012-07-25 中国人民解放军第四军医大学 一种基于多串联表位的重组腺病毒hiv疫苗及其制备方法
CN111315407B (zh) * 2018-09-11 2023-05-02 上海市公共卫生临床中心 一种广谱抗流感疫苗免疫原及其应用
US12194089B2 (en) * 2020-02-04 2025-01-14 CureVac SE Coronavirus vaccine
US12269846B2 (en) * 2020-03-05 2025-04-08 Swey-Shen Chen CoV-2 (CoV-n) antibody neutralizing and CTL vaccines using protein scaffolds and molecular evolution
US20250108108A1 (en) * 2020-04-14 2025-04-03 The Regents Of The University Of California Hybrid flu-coronavirus vaccine
WO2022167571A1 (en) * 2021-02-04 2022-08-11 Imba - Institut Für Molekulare Biotechnologie Gmbh Treatment and method of identifying coronavirus therapeutics

Similar Documents

Publication Publication Date Title
JP2023521837A5 (https=)
CN111217917B (zh) 一种新型冠状病毒SARS-CoV-2疫苗及其制备方法
US12296002B2 (en) Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Yi et al. Construction of a DNA vaccine and its protective effect on largemouth bass (Micropterus salmoides) challenged with largemouth bass virus (LMBV)
Fu et al. Protective immunity against infectious spleen and kidney necrosis virus induced by immunization with DNA plasmid containing mcp gene in Chinese perch Siniperca chuatsi
CN113666990B (zh) 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用
TW202140794A (zh) 疫苗及其誘導對sars-cov2之免疫反應之用途
Zhang et al. Immune response and protective effect against spring viremia of carp virus induced by intramuscular vaccination with a SWCNTs-DNA vaccine encoding matrix protein
Pei et al. A developed subunit vaccine based on fiber protein VP56 of grass carp reovirus providing immune protection against grass carp hemorrhagic disease
Zhu et al. Preliminary screening and immunogenicity analysis of antigenic epitopes of spring viremia of carp virus
JP2008529558A5 (https=)
Zhang et al. Single-walled carbon nanotubes as delivery vehicles enhance the immunoprotective effect of a DNA vaccine against spring viremia of carp virus in common carp
CN111744003B (zh) 趋化因子cx3cl1在制备疫苗中的应用和幽门螺旋杆菌疫苗
WO2021254473A1 (en) Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (sars-cov-2)
TW202027785A (zh) 經修飾之pedv棘蛋白
Giese et al. Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus
Sahle et al. Molecular epidemiology of serotype O foot-and-mouth disease virus isolated from cattle in Ethiopia between 1979-2001
JP2013523084A5 (https=)
Wang et al. Analysis of the genome sequence of infectious hematopoietic necrosis virus HLJ-09 in China
Qiu et al. Dominant antigen of grass carp Reovirus and immunity assessment with DNA vaccine for grass carp
Wang et al. Identification of immunodominant T-cell epitopes in membrane protein of highly pathogenic porcine reproductive and respiratory syndrome virus
CN101955941B (zh) 猪干扰素基因家族及其作为抗猪蓝耳病药物及疫苗佐剂的应用
RU2011150283A (ru) Пептиды ттк и вакцины, их содержащие
JP2012526519A5 (https=)
CN102321638B (zh) 一种新的猪繁殖与呼吸综合征病毒orf5修饰基因及其应用